| Product NDC: | 59630-801 |
| Proprietary Name: | Twinject |
| Non Proprietary Name: | Epinephrine |
| Active Ingredient(s): | 1 mg/mL & nbsp; Epinephrine |
| Administration Route(s): | INTRAMUSCULAR; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59630-801 |
| Labeler Name: | Shionogi Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020800 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030530 |
| Package NDC: | 59630-801-01 |
| Package Description: | 1 SYRINGE in 1 CARTON (59630-801-01) > .15 mL in 1 SYRINGE |
| NDC Code | 59630-801-01 |
| Proprietary Name | Twinject |
| Package Description | 1 SYRINGE in 1 CARTON (59630-801-01) > .15 mL in 1 SYRINGE |
| Product NDC | 59630-801 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Epinephrine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; SUBCUTANEOUS |
| Start Marketing Date | 20030530 |
| Marketing Category Name | NDA |
| Labeler Name | Shionogi Pharma, Inc. |
| Substance Name | EPINEPHRINE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |